Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tanimilast in allergic asthma
NCT01689571Phase 2Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Oct 2012
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tanimilast in asthma, sponsored by Chiesi Farmaceutici S.p.A.. Started Oct 2012; status: completed.
02
Drugs
tanimilast
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01689571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01689571.